CN Stock MarketDetailed Quotes

603567 HeiLongJiang ZBD Pharmaceutical

Watchlist
  • 10.18
  • -0.12-1.17%
Trading Sep 12 11:12 CST
9.59BMarket Cap12.57P/E (TTM)

HeiLongJiang ZBD Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HeiLongJiang ZBD Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 27, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
544.09M
--
+88.82%
Net Income
--
101.75M
--
+176.35%
Analyst Rating
Strong Buy

Sep 11, 2024

HeiLongJiang ZBD Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2021/FY4.127B / 4.049B--
DatePeriodRevenue/EstimateEarnings Call
--2021/FY4.127B / 4.049B--

HeiLongJiang ZBD Pharmaceutical Earnings Reports

  • Heilongjiang ZBD Pharmaceutical Co., Ltd. 2024 Semi-annual Report

    Aug 27 00:00

  • Heilongjiang ZBD Pharmaceutical Co., Ltd. 2024 Interim Report Summary

    Aug 27 00:00

  • Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Annual Report 2023 - Revised Edition Summary.

    Aug 8 00:00

  • Heilongjiang ZBD Pharmaceutical Co., Ltd. 2023 Semi-Annual Report - Revised Edition Summary.

    Aug 8 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 11, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg